nodes	percent_of_prediction	percent_of_DWPC	metapath
Rivaroxaban—CYP3A5—Dapsone—systemic lupus erythematosus	0.0625	0.0924	CbGbCtD
Rivaroxaban—CYP3A5—Mycophenolate mofetil—systemic lupus erythematosus	0.0542	0.0801	CbGbCtD
Rivaroxaban—ABCB1—Methylprednisolone—systemic lupus erythematosus	0.0465	0.0688	CbGbCtD
Rivaroxaban—CYP3A5—Hydrocortisone—systemic lupus erythematosus	0.0435	0.0643	CbGbCtD
Rivaroxaban—CYP3A5—Cyclosporine—systemic lupus erythematosus	0.0411	0.0607	CbGbCtD
Rivaroxaban—ABCB1—Mycophenolate mofetil—systemic lupus erythematosus	0.0353	0.0522	CbGbCtD
Rivaroxaban—ABCB1—Betamethasone—systemic lupus erythematosus	0.0302	0.0448	CbGbCtD
Rivaroxaban—ABCB1—Prednisolone—systemic lupus erythematosus	0.0298	0.0442	CbGbCtD
Rivaroxaban—ABCB1—Hydrocortisone—systemic lupus erythematosus	0.0283	0.0419	CbGbCtD
Rivaroxaban—ABCB1—Prednisone—systemic lupus erythematosus	0.0282	0.0417	CbGbCtD
Rivaroxaban—CYP3A4—Methylprednisolone—systemic lupus erythematosus	0.0279	0.0412	CbGbCtD
Rivaroxaban—CYP3A5—Dexamethasone—systemic lupus erythematosus	0.027	0.04	CbGbCtD
Rivaroxaban—ABCB1—Cyclosporine—systemic lupus erythematosus	0.0267	0.0395	CbGbCtD
Rivaroxaban—CYP3A4—Dapsone—systemic lupus erythematosus	0.0244	0.036	CbGbCtD
Rivaroxaban—CYP3A4—Mycophenolate mofetil—systemic lupus erythematosus	0.0211	0.0313	CbGbCtD
Rivaroxaban—CYP3A4—Triamcinolone—systemic lupus erythematosus	0.0211	0.0313	CbGbCtD
Rivaroxaban—CYP3A4—Betamethasone—systemic lupus erythematosus	0.0181	0.0268	CbGbCtD
Rivaroxaban—CYP3A4—Prednisolone—systemic lupus erythematosus	0.0179	0.0265	CbGbCtD
Rivaroxaban—ABCB1—Dexamethasone—systemic lupus erythematosus	0.0176	0.026	CbGbCtD
Rivaroxaban—CYP3A4—Hydrocortisone—systemic lupus erythematosus	0.017	0.0251	CbGbCtD
Rivaroxaban—CYP3A4—Prednisone—systemic lupus erythematosus	0.0169	0.025	CbGbCtD
Rivaroxaban—CYP3A4—Cyclosporine—systemic lupus erythematosus	0.016	0.0237	CbGbCtD
Rivaroxaban—F10—Extrinsic Pathway—F3—systemic lupus erythematosus	0.0142	0.15	CbGpPWpGaD
Rivaroxaban—ABCB1—Methotrexate—systemic lupus erythematosus	0.0141	0.0209	CbGbCtD
Rivaroxaban—CYP3A4—Dexamethasone—systemic lupus erythematosus	0.0105	0.0156	CbGbCtD
Rivaroxaban—F10—blood plasma—systemic lupus erythematosus	0.00619	0.172	CbGeAlD
Rivaroxaban—F10—Complement and Coagulation Cascades—CR2—systemic lupus erythematosus	0.00364	0.0385	CbGpPWpGaD
Rivaroxaban—F10—Beta2 integrin cell surface interactions—ITGAX—systemic lupus erythematosus	0.00352	0.0372	CbGpPWpGaD
Rivaroxaban—F10—Transport of gamma-carboxylated protein precursors from the endoplasmic reticulum to the Golgi apparatus—F2—systemic lupus erythematosus	0.00337	0.0356	CbGpPWpGaD
Rivaroxaban—F10—Complement and Coagulation Cascades—C1R—systemic lupus erythematosus	0.00325	0.0343	CbGpPWpGaD
Rivaroxaban—F10—Complement and Coagulation Cascades—C1S—systemic lupus erythematosus	0.00325	0.0343	CbGpPWpGaD
Rivaroxaban—F10—Gamma-carboxylation of protein precursors—F2—systemic lupus erythematosus	0.00307	0.0324	CbGpPWpGaD
Rivaroxaban—F10—Removal of aminoterminal propeptides from gamma-carboxylated proteins—F2—systemic lupus erythematosus	0.00307	0.0324	CbGpPWpGaD
Rivaroxaban—F10—Formation of Fibrin Clot (Clotting Cascade)—F3—systemic lupus erythematosus	0.00292	0.0308	CbGpPWpGaD
Rivaroxaban—F10—Beta2 integrin cell surface interactions—ITGAM—systemic lupus erythematosus	0.00263	0.0278	CbGpPWpGaD
Rivaroxaban—CYP2J2—nephron tubule—systemic lupus erythematosus	0.00261	0.0727	CbGeAlD
Rivaroxaban—F10—Gamma-carboxylation, transport, and amino-terminal cleavage of proteins—F2—systemic lupus erythematosus	0.00261	0.0276	CbGpPWpGaD
Rivaroxaban—CYP3A4—urine—systemic lupus erythematosus	0.00257	0.0714	CbGeAlD
Rivaroxaban—F10—Beta2 integrin cell surface interactions—FCGR2A—systemic lupus erythematosus	0.00251	0.0265	CbGpPWpGaD
Rivaroxaban—F10—Complement and Coagulation Cascades—C1QA—systemic lupus erythematosus	0.00246	0.026	CbGpPWpGaD
Rivaroxaban—CYP2J2—skin of body—systemic lupus erythematosus	0.00244	0.0678	CbGeAlD
Rivaroxaban—F10—Complement and Coagulation Cascades—C4B—systemic lupus erythematosus	0.00235	0.0248	CbGpPWpGaD
Rivaroxaban—F10—tendon—systemic lupus erythematosus	0.00226	0.063	CbGeAlD
Rivaroxaban—F10—Complement and Coagulation Cascades—CR1—systemic lupus erythematosus	0.00209	0.0221	CbGpPWpGaD
Rivaroxaban—F10—Complement and Coagulation Cascades—CFB—systemic lupus erythematosus	0.002	0.0211	CbGpPWpGaD
Rivaroxaban—F10—lung—systemic lupus erythematosus	0.00199	0.0553	CbGeAlD
Rivaroxaban—F10—Complement and Coagulation Cascades—F3—systemic lupus erythematosus	0.00197	0.0208	CbGpPWpGaD
Rivaroxaban—CYP2J2—tendon—systemic lupus erythematosus	0.00186	0.0516	CbGeAlD
Rivaroxaban—CYP3A5—blood plasma—systemic lupus erythematosus	0.00178	0.0496	CbGeAlD
Rivaroxaban—F10—Complement and Coagulation Cascades—CLU—systemic lupus erythematosus	0.00178	0.0188	CbGpPWpGaD
Rivaroxaban—F10—Common Pathway—F2—systemic lupus erythematosus	0.00176	0.0186	CbGpPWpGaD
Rivaroxaban—CYP2J2—lung—systemic lupus erythematosus	0.00163	0.0453	CbGeAlD
Rivaroxaban—F10—Beta2 integrin cell surface interactions—CD40LG—systemic lupus erythematosus	0.00155	0.0164	CbGpPWpGaD
Rivaroxaban—CYP2J2—nervous system—systemic lupus erythematosus	0.00151	0.0419	CbGeAlD
Rivaroxaban—F10—Intrinsic Pathway—F2—systemic lupus erythematosus	0.0015	0.0158	CbGpPWpGaD
Rivaroxaban—F10—Blood Clotting Cascade—F2—systemic lupus erythematosus	0.0015	0.0158	CbGpPWpGaD
Rivaroxaban—CYP2J2—central nervous system—systemic lupus erythematosus	0.00145	0.0404	CbGeAlD
Rivaroxaban—F10—Beta2 integrin cell surface interactions—C3—systemic lupus erythematosus	0.00137	0.0145	CbGpPWpGaD
Rivaroxaban—CYP3A4—blood plasma—systemic lupus erythematosus	0.00134	0.0373	CbGeAlD
Rivaroxaban—F10—PTM: gamma carboxylation, hypusine formation and arylsulfatase activation—F2—systemic lupus erythematosus	0.00124	0.0131	CbGpPWpGaD
Rivaroxaban—F10—Formation of Fibrin Clot (Clotting Cascade)—F2—systemic lupus erythematosus	0.00101	0.0107	CbGpPWpGaD
Rivaroxaban—CYP2J2—Cytochrome P450 - arranged by substrate type—RXRA—systemic lupus erythematosus	0.000969	0.0102	CbGpPWpGaD
Rivaroxaban—ABCB1—blood plasma—systemic lupus erythematosus	0.000948	0.0264	CbGeAlD
Rivaroxaban—CYP3A5—nephron tubule—systemic lupus erythematosus	0.00092	0.0256	CbGeAlD
Rivaroxaban—ABCB1—Allograft Rejection—IL21—systemic lupus erythematosus	0.000815	0.0086	CbGpPWpGaD
Rivaroxaban—CYP3A5—kidney—systemic lupus erythematosus	0.000809	0.0225	CbGeAlD
Rivaroxaban—CYP3A5—cortex of kidney—systemic lupus erythematosus	0.000788	0.0219	CbGeAlD
Rivaroxaban—CYP2J2—Phase 1 - Functionalization of compounds—RXRA—systemic lupus erythematosus	0.000786	0.00829	CbGpPWpGaD
Rivaroxaban—F10—Complement and Coagulation Cascades—C3—systemic lupus erythematosus	0.000777	0.0082	CbGpPWpGaD
Rivaroxaban—CYP2J2—Biological oxidations—NAT2—systemic lupus erythematosus	0.000744	0.00786	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metapathway biotransformation—NAT2—systemic lupus erythematosus	0.000734	0.00775	CbGpPWpGaD
Rivaroxaban—F10—Post-translational protein modification—MAN2A1—systemic lupus erythematosus	0.000698	0.00736	CbGpPWpGaD
Rivaroxaban—F10—Complement and Coagulation Cascades—F2—systemic lupus erythematosus	0.000682	0.0072	CbGpPWpGaD
Rivaroxaban—CYP3A4—kidney—systemic lupus erythematosus	0.000607	0.0169	CbGeAlD
Rivaroxaban—CYP3A5—lung—systemic lupus erythematosus	0.000573	0.0159	CbGeAlD
Rivaroxaban—CYP2J2—Arachidonic acid metabolism—PTGS2—systemic lupus erythematosus	0.000557	0.00588	CbGpPWpGaD
Rivaroxaban—CYP3A4—Liver X Receptor Pathway—RXRA—systemic lupus erythematosus	0.000544	0.00575	CbGpPWpGaD
Rivaroxaban—ABCB1—Drug Induction of Bile Acid Pathway—VDR—systemic lupus erythematosus	0.000524	0.00553	CbGpPWpGaD
Rivaroxaban—ABCB1—nephron tubule—systemic lupus erythematosus	0.000489	0.0136	CbGeAlD
Rivaroxaban—CYP3A5—Constitutive Androstane Receptor Pathway—RXRA—systemic lupus erythematosus	0.000462	0.00487	CbGpPWpGaD
Rivaroxaban—ABCB1—kidney—systemic lupus erythematosus	0.00043	0.012	CbGeAlD
Rivaroxaban—ABCB1—cortex of kidney—systemic lupus erythematosus	0.000418	0.0116	CbGeAlD
Rivaroxaban—CYP2J2—Biological oxidations—RXRA—systemic lupus erythematosus	0.000417	0.0044	CbGpPWpGaD
Rivaroxaban—CYP3A4—nervous system—systemic lupus erythematosus	0.000398	0.0111	CbGeAlD
Rivaroxaban—ABCB1—Allograft Rejection—C4A—systemic lupus erythematosus	0.000398	0.0042	CbGpPWpGaD
Rivaroxaban—CYP3A4—central nervous system—systemic lupus erythematosus	0.000383	0.0107	CbGeAlD
Rivaroxaban—ABCB1—lymphoid tissue—systemic lupus erythematosus	0.000369	0.0103	CbGeAlD
Rivaroxaban—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—LYN—systemic lupus erythematosus	0.000358	0.00378	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—ITGAX—systemic lupus erythematosus	0.000358	0.00378	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—F3—systemic lupus erythematosus	0.000353	0.00372	CbGpPWpGaD
Rivaroxaban—ABCB1—Constitutive Androstane Receptor Pathway—RXRA—systemic lupus erythematosus	0.000349	0.00368	CbGpPWpGaD
Rivaroxaban—ABCB1—bone marrow—systemic lupus erythematosus	0.000336	0.00935	CbGeAlD
Rivaroxaban—F10—Metabolism of proteins—MAN2A1—systemic lupus erythematosus	0.000331	0.00349	CbGpPWpGaD
Rivaroxaban—CYP3A4—Farnesoid X Receptor  Pathway—RXRA—systemic lupus erythematosus	0.000326	0.00344	CbGpPWpGaD
Rivaroxaban—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—systemic lupus erythematosus	0.000323	0.0034	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—CLU—systemic lupus erythematosus	0.000319	0.00337	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—P2RY12—systemic lupus erythematosus	0.000309	0.00326	CbGpPWpGaD
Rivaroxaban—ABCB1—lung—systemic lupus erythematosus	0.000304	0.00847	CbGeAlD
Rivaroxaban—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—systemic lupus erythematosus	0.000301	0.00317	CbGpPWpGaD
Rivaroxaban—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—GADD45A—systemic lupus erythematosus	0.0003	0.00317	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—SELE—systemic lupus erythematosus	0.000284	0.003	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—CSK—systemic lupus erythematosus	0.000284	0.003	CbGpPWpGaD
Rivaroxaban—ABCB1—nervous system—systemic lupus erythematosus	0.000282	0.00784	CbGeAlD
Rivaroxaban—CYP3A5—Cytochrome P450 - arranged by substrate type—RXRA—systemic lupus erythematosus	0.000279	0.00295	CbGpPWpGaD
Rivaroxaban—ABCB1—Allograft Rejection—FOXP3—systemic lupus erythematosus	0.000278	0.00294	CbGpPWpGaD
Rivaroxaban—ABCB1—HIF-1-alpha transcription factor network—ETS1—systemic lupus erythematosus	0.000277	0.00292	CbGpPWpGaD
Rivaroxaban—ABCB1—central nervous system—systemic lupus erythematosus	0.000271	0.00755	CbGeAlD
Rivaroxaban—F10—Hemostasis—ITGAM—systemic lupus erythematosus	0.000267	0.00282	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—LYN—systemic lupus erythematosus	0.000258	0.00273	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—SH2B3—systemic lupus erythematosus	0.000253	0.00267	CbGpPWpGaD
Rivaroxaban—ABCB1—HIF-1-alpha transcription factor network—CXCL12—systemic lupus erythematosus	0.000227	0.0024	CbGpPWpGaD
Rivaroxaban—Pain—Cyclosporine—systemic lupus erythematosus	0.000227	0.00117	CcSEcCtD
Rivaroxaban—Constipation—Cyclosporine—systemic lupus erythematosus	0.000227	0.00117	CcSEcCtD
Rivaroxaban—Dry mouth—Triamcinolone—systemic lupus erythematosus	0.000226	0.00117	CcSEcCtD
Rivaroxaban—CYP3A5—Phase 1 - Functionalization of compounds—RXRA—systemic lupus erythematosus	0.000226	0.00239	CbGpPWpGaD
Rivaroxaban—Renal failure—Methotrexate—systemic lupus erythematosus	0.000226	0.00117	CcSEcCtD
Rivaroxaban—Angioedema—Dexamethasone—systemic lupus erythematosus	0.000226	0.00117	CcSEcCtD
Rivaroxaban—Angioedema—Betamethasone—systemic lupus erythematosus	0.000226	0.00117	CcSEcCtD
Rivaroxaban—Angiopathy—Prednisone—systemic lupus erythematosus	0.000224	0.00116	CcSEcCtD
Rivaroxaban—Gastrointestinal disorder—Mycophenolate mofetil—systemic lupus erythematosus	0.000223	0.00115	CcSEcCtD
Rivaroxaban—Immune system disorder—Prednisone—systemic lupus erythematosus	0.000223	0.00115	CcSEcCtD
Rivaroxaban—Malaise—Betamethasone—systemic lupus erythematosus	0.000223	0.00115	CcSEcCtD
Rivaroxaban—Malaise—Dexamethasone—systemic lupus erythematosus	0.000223	0.00115	CcSEcCtD
Rivaroxaban—Anaphylactic shock—Triamcinolone—systemic lupus erythematosus	0.000222	0.00115	CcSEcCtD
Rivaroxaban—Oedema—Triamcinolone—systemic lupus erythematosus	0.000222	0.00115	CcSEcCtD
Rivaroxaban—Anaphylactic shock—Methylprednisolone—systemic lupus erythematosus	0.000221	0.00114	CcSEcCtD
Rivaroxaban—Syncope—Dexamethasone—systemic lupus erythematosus	0.000221	0.00114	CcSEcCtD
Rivaroxaban—Syncope—Betamethasone—systemic lupus erythematosus	0.000221	0.00114	CcSEcCtD
Rivaroxaban—Pain—Mycophenolate mofetil—systemic lupus erythematosus	0.000221	0.00114	CcSEcCtD
Rivaroxaban—Constipation—Mycophenolate mofetil—systemic lupus erythematosus	0.000221	0.00114	CcSEcCtD
Rivaroxaban—Infection—Triamcinolone—systemic lupus erythematosus	0.000221	0.00114	CcSEcCtD
Rivaroxaban—Hypotension—Hydrocortisone—systemic lupus erythematosus	0.00022	0.00114	CcSEcCtD
Rivaroxaban—Infection—Methylprednisolone—systemic lupus erythematosus	0.00022	0.00114	CcSEcCtD
Rivaroxaban—ABCB1—Allograft Rejection—IL17A—systemic lupus erythematosus	0.000219	0.00231	CbGpPWpGaD
Rivaroxaban—Haematuria—Methotrexate—systemic lupus erythematosus	0.000219	0.00113	CcSEcCtD
Rivaroxaban—Feeling abnormal—Cyclosporine—systemic lupus erythematosus	0.000219	0.00113	CcSEcCtD
Rivaroxaban—Vomiting—Leflunomide—systemic lupus erythematosus	0.000219	0.00113	CcSEcCtD
Rivaroxaban—Shock—Triamcinolone—systemic lupus erythematosus	0.000218	0.00113	CcSEcCtD
Rivaroxaban—Shock—Methylprednisolone—systemic lupus erythematosus	0.000218	0.00113	CcSEcCtD
Rivaroxaban—Hepatobiliary disease—Methotrexate—systemic lupus erythematosus	0.000217	0.00112	CcSEcCtD
Rivaroxaban—Nervous system disorder—Methylprednisolone—systemic lupus erythematosus	0.000217	0.00112	CcSEcCtD
Rivaroxaban—Gastrointestinal pain—Cyclosporine—systemic lupus erythematosus	0.000217	0.00112	CcSEcCtD
Rivaroxaban—Loss of consciousness—Betamethasone—systemic lupus erythematosus	0.000217	0.00112	CcSEcCtD
Rivaroxaban—Loss of consciousness—Dexamethasone—systemic lupus erythematosus	0.000217	0.00112	CcSEcCtD
Rivaroxaban—Epistaxis—Methotrexate—systemic lupus erythematosus	0.000217	0.00112	CcSEcCtD
Rivaroxaban—Rash—Leflunomide—systemic lupus erythematosus	0.000217	0.00112	CcSEcCtD
Rivaroxaban—Tachycardia—Triamcinolone—systemic lupus erythematosus	0.000217	0.00112	CcSEcCtD
Rivaroxaban—Dermatitis—Leflunomide—systemic lupus erythematosus	0.000217	0.00112	CcSEcCtD
Rivaroxaban—Nausea—Azathioprine—systemic lupus erythematosus	0.000216	0.00112	CcSEcCtD
Rivaroxaban—Tachycardia—Methylprednisolone—systemic lupus erythematosus	0.000216	0.00112	CcSEcCtD
Rivaroxaban—Headache—Leflunomide—systemic lupus erythematosus	0.000215	0.00111	CcSEcCtD
Rivaroxaban—Skin disorder—Methylprednisolone—systemic lupus erythematosus	0.000215	0.00111	CcSEcCtD
Rivaroxaban—CYP3A4—Constitutive Androstane Receptor Pathway—RXRA—systemic lupus erythematosus	0.000215	0.00227	CbGpPWpGaD
Rivaroxaban—CYP3A5—Biological oxidations—NAT2—systemic lupus erythematosus	0.000215	0.00226	CbGpPWpGaD
Rivaroxaban—Agranulocytosis—Methotrexate—systemic lupus erythematosus	0.000215	0.00111	CcSEcCtD
Rivaroxaban—Feeling abnormal—Mycophenolate mofetil—systemic lupus erythematosus	0.000213	0.0011	CcSEcCtD
Rivaroxaban—CYP3A5—Metapathway biotransformation—NAT2—systemic lupus erythematosus	0.000212	0.00223	CbGpPWpGaD
Rivaroxaban—Gastrointestinal pain—Mycophenolate mofetil—systemic lupus erythematosus	0.000212	0.00109	CcSEcCtD
Rivaroxaban—Urticaria—Cyclosporine—systemic lupus erythematosus	0.000211	0.00109	CcSEcCtD
Rivaroxaban—Abdominal pain—Cyclosporine—systemic lupus erythematosus	0.00021	0.00108	CcSEcCtD
Rivaroxaban—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—systemic lupus erythematosus	0.00021	0.00221	CbGpPWpGaD
Rivaroxaban—Discomfort—Dexamethasone—systemic lupus erythematosus	0.000208	0.00107	CcSEcCtD
Rivaroxaban—Discomfort—Betamethasone—systemic lupus erythematosus	0.000208	0.00107	CcSEcCtD
Rivaroxaban—Dyspepsia—Hydrocortisone—systemic lupus erythematosus	0.000208	0.00107	CcSEcCtD
Rivaroxaban—Haemoglobin—Methotrexate—systemic lupus erythematosus	0.000207	0.00107	CcSEcCtD
Rivaroxaban—Hypotension—Methylprednisolone—systemic lupus erythematosus	0.000207	0.00107	CcSEcCtD
Rivaroxaban—Pain—Prednisolone—systemic lupus erythematosus	0.000206	0.00107	CcSEcCtD
Rivaroxaban—Hepatitis—Methotrexate—systemic lupus erythematosus	0.000206	0.00107	CcSEcCtD
Rivaroxaban—Haemorrhage—Methotrexate—systemic lupus erythematosus	0.000206	0.00107	CcSEcCtD
Rivaroxaban—Urticaria—Mycophenolate mofetil—systemic lupus erythematosus	0.000206	0.00106	CcSEcCtD
Rivaroxaban—Abdominal pain—Mycophenolate mofetil—systemic lupus erythematosus	0.000205	0.00106	CcSEcCtD
Rivaroxaban—Nausea—Leflunomide—systemic lupus erythematosus	0.000204	0.00106	CcSEcCtD
Rivaroxaban—ABCB1—Allograft Rejection—IL12B—systemic lupus erythematosus	0.000204	0.00215	CbGpPWpGaD
Rivaroxaban—Urinary tract disorder—Methotrexate—systemic lupus erythematosus	0.000204	0.00105	CcSEcCtD
Rivaroxaban—Gastrointestinal disorder—Hydrocortisone—systemic lupus erythematosus	0.000204	0.00105	CcSEcCtD
Rivaroxaban—Fatigue—Hydrocortisone—systemic lupus erythematosus	0.000203	0.00105	CcSEcCtD
Rivaroxaban—F10—Post-translational protein modification—F2—systemic lupus erythematosus	0.000203	0.00214	CbGpPWpGaD
Rivaroxaban—Urethral disorder—Methotrexate—systemic lupus erythematosus	0.000202	0.00105	CcSEcCtD
Rivaroxaban—Pain—Hydrocortisone—systemic lupus erythematosus	0.000202	0.00104	CcSEcCtD
Rivaroxaban—Oedema—Dexamethasone—systemic lupus erythematosus	0.000201	0.00104	CcSEcCtD
Rivaroxaban—Oedema—Betamethasone—systemic lupus erythematosus	0.000201	0.00104	CcSEcCtD
Rivaroxaban—Anaphylactic shock—Dexamethasone—systemic lupus erythematosus	0.000201	0.00104	CcSEcCtD
Rivaroxaban—Anaphylactic shock—Betamethasone—systemic lupus erythematosus	0.000201	0.00104	CcSEcCtD
Rivaroxaban—Infection—Betamethasone—systemic lupus erythematosus	0.0002	0.00103	CcSEcCtD
Rivaroxaban—Infection—Dexamethasone—systemic lupus erythematosus	0.0002	0.00103	CcSEcCtD
Rivaroxaban—Ill-defined disorder—Prednisone—systemic lupus erythematosus	0.000199	0.00103	CcSEcCtD
Rivaroxaban—F10—Hemostasis—IFNA1—systemic lupus erythematosus	0.000199	0.0021	CbGpPWpGaD
Rivaroxaban—Feeling abnormal—Prednisolone—systemic lupus erythematosus	0.000199	0.00103	CcSEcCtD
Rivaroxaban—Anaemia—Prednisone—systemic lupus erythematosus	0.000199	0.00103	CcSEcCtD
Rivaroxaban—Shock—Betamethasone—systemic lupus erythematosus	0.000198	0.00102	CcSEcCtD
Rivaroxaban—Shock—Dexamethasone—systemic lupus erythematosus	0.000198	0.00102	CcSEcCtD
Rivaroxaban—Dyspnoea—Triamcinolone—systemic lupus erythematosus	0.000198	0.00102	CcSEcCtD
Rivaroxaban—Nervous system disorder—Betamethasone—systemic lupus erythematosus	0.000198	0.00102	CcSEcCtD
Rivaroxaban—Nervous system disorder—Dexamethasone—systemic lupus erythematosus	0.000198	0.00102	CcSEcCtD
Rivaroxaban—ABCB1—Allograft Rejection—CXCL12—systemic lupus erythematosus	0.000197	0.00208	CbGpPWpGaD
Rivaroxaban—Tachycardia—Dexamethasone—systemic lupus erythematosus	0.000197	0.00102	CcSEcCtD
Rivaroxaban—Tachycardia—Betamethasone—systemic lupus erythematosus	0.000197	0.00102	CcSEcCtD
Rivaroxaban—Angioedema—Prednisone—systemic lupus erythematosus	0.000196	0.00102	CcSEcCtD
Rivaroxaban—Hypersensitivity—Cyclosporine—systemic lupus erythematosus	0.000195	0.00101	CcSEcCtD
Rivaroxaban—Dyspepsia—Triamcinolone—systemic lupus erythematosus	0.000195	0.00101	CcSEcCtD
Rivaroxaban—Erythema multiforme—Methotrexate—systemic lupus erythematosus	0.000195	0.00101	CcSEcCtD
Rivaroxaban—Dyspepsia—Methylprednisolone—systemic lupus erythematosus	0.000195	0.00101	CcSEcCtD
Rivaroxaban—ABCB1—Allograft Rejection—CD40—systemic lupus erythematosus	0.000194	0.00205	CbGpPWpGaD
Rivaroxaban—Feeling abnormal—Hydrocortisone—systemic lupus erythematosus	0.000194	0.001	CcSEcCtD
Rivaroxaban—F10—Hemostasis—RASGRP1—systemic lupus erythematosus	0.000194	0.00205	CbGpPWpGaD
Rivaroxaban—Malaise—Prednisone—systemic lupus erythematosus	0.000194	0.001	CcSEcCtD
Rivaroxaban—Eye disorder—Methotrexate—systemic lupus erythematosus	0.000193	0.000997	CcSEcCtD
Rivaroxaban—Gastrointestinal pain—Hydrocortisone—systemic lupus erythematosus	0.000193	0.000996	CcSEcCtD
Rivaroxaban—Syncope—Prednisone—systemic lupus erythematosus	0.000193	0.000996	CcSEcCtD
Rivaroxaban—Urticaria—Prednisolone—systemic lupus erythematosus	0.000192	0.000991	CcSEcCtD
Rivaroxaban—ABCB1—Allograft Rejection—CTLA4—systemic lupus erythematosus	0.000192	0.00202	CbGpPWpGaD
Rivaroxaban—Cardiac disorder—Methotrexate—systemic lupus erythematosus	0.000192	0.00099	CcSEcCtD
Rivaroxaban—Fatigue—Triamcinolone—systemic lupus erythematosus	0.000191	0.000989	CcSEcCtD
Rivaroxaban—Fatigue—Methylprednisolone—systemic lupus erythematosus	0.000191	0.000987	CcSEcCtD
Rivaroxaban—Hypersensitivity—Mycophenolate mofetil—systemic lupus erythematosus	0.000191	0.000985	CcSEcCtD
Rivaroxaban—Asthenia—Cyclosporine—systemic lupus erythematosus	0.00019	0.000984	CcSEcCtD
Rivaroxaban—Pain—Triamcinolone—systemic lupus erythematosus	0.00019	0.000981	CcSEcCtD
Rivaroxaban—Loss of consciousness—Prednisone—systemic lupus erythematosus	0.000189	0.000976	CcSEcCtD
Rivaroxaban—Hypotension—Betamethasone—systemic lupus erythematosus	0.000188	0.000973	CcSEcCtD
Rivaroxaban—Hypotension—Dexamethasone—systemic lupus erythematosus	0.000188	0.000973	CcSEcCtD
Rivaroxaban—Pruritus—Cyclosporine—systemic lupus erythematosus	0.000188	0.00097	CcSEcCtD
Rivaroxaban—Urticaria—Hydrocortisone—systemic lupus erythematosus	0.000187	0.000968	CcSEcCtD
Rivaroxaban—Angiopathy—Methotrexate—systemic lupus erythematosus	0.000187	0.000968	CcSEcCtD
Rivaroxaban—Immune system disorder—Methotrexate—systemic lupus erythematosus	0.000186	0.000963	CcSEcCtD
Rivaroxaban—Abdominal pain—Hydrocortisone—systemic lupus erythematosus	0.000186	0.000963	CcSEcCtD
Rivaroxaban—Mediastinal disorder—Methotrexate—systemic lupus erythematosus	0.000186	0.000961	CcSEcCtD
Rivaroxaban—Asthenia—Mycophenolate mofetil—systemic lupus erythematosus	0.000186	0.00096	CcSEcCtD
Rivaroxaban—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—systemic lupus erythematosus	0.000185	0.00196	CbGpPWpGaD
Rivaroxaban—Pruritus—Mycophenolate mofetil—systemic lupus erythematosus	0.000183	0.000946	CcSEcCtD
Rivaroxaban—Feeling abnormal—Triamcinolone—systemic lupus erythematosus	0.000183	0.000946	CcSEcCtD
Rivaroxaban—Feeling abnormal—Methylprednisolone—systemic lupus erythematosus	0.000183	0.000943	CcSEcCtD
Rivaroxaban—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic lupus erythematosus	0.000182	0.000939	CcSEcCtD
Rivaroxaban—Diarrhoea—Cyclosporine—systemic lupus erythematosus	0.000182	0.000938	CcSEcCtD
Rivaroxaban—Gastrointestinal pain—Methylprednisolone—systemic lupus erythematosus	0.000181	0.000936	CcSEcCtD
Rivaroxaban—Discomfort—Prednisone—systemic lupus erythematosus	0.000181	0.000934	CcSEcCtD
Rivaroxaban—Hypersensitivity—Prednisolone—systemic lupus erythematosus	0.000178	0.000919	CcSEcCtD
Rivaroxaban—Dyspepsia—Betamethasone—systemic lupus erythematosus	0.000177	0.000916	CcSEcCtD
Rivaroxaban—Dyspepsia—Dexamethasone—systemic lupus erythematosus	0.000177	0.000916	CcSEcCtD
Rivaroxaban—Diarrhoea—Mycophenolate mofetil—systemic lupus erythematosus	0.000177	0.000915	CcSEcCtD
Rivaroxaban—Urticaria—Triamcinolone—systemic lupus erythematosus	0.000176	0.000912	CcSEcCtD
Rivaroxaban—Urticaria—Methylprednisolone—systemic lupus erythematosus	0.000176	0.000909	CcSEcCtD
Rivaroxaban—Dizziness—Cyclosporine—systemic lupus erythematosus	0.000175	0.000907	CcSEcCtD
Rivaroxaban—Anaphylactic shock—Prednisone—systemic lupus erythematosus	0.000175	0.000907	CcSEcCtD
Rivaroxaban—Oedema—Prednisone—systemic lupus erythematosus	0.000175	0.000907	CcSEcCtD
Rivaroxaban—Abdominal pain—Methylprednisolone—systemic lupus erythematosus	0.000175	0.000905	CcSEcCtD
Rivaroxaban—Infection—Prednisone—systemic lupus erythematosus	0.000174	0.000901	CcSEcCtD
Rivaroxaban—Gastrointestinal disorder—Dexamethasone—systemic lupus erythematosus	0.000174	0.000899	CcSEcCtD
Rivaroxaban—Gastrointestinal disorder—Betamethasone—systemic lupus erythematosus	0.000174	0.000899	CcSEcCtD
Rivaroxaban—Back pain—Methotrexate—systemic lupus erythematosus	0.000174	0.000898	CcSEcCtD
Rivaroxaban—Hypersensitivity—Hydrocortisone—systemic lupus erythematosus	0.000174	0.000898	CcSEcCtD
Rivaroxaban—Fatigue—Dexamethasone—systemic lupus erythematosus	0.000174	0.000898	CcSEcCtD
Rivaroxaban—Fatigue—Betamethasone—systemic lupus erythematosus	0.000174	0.000898	CcSEcCtD
Rivaroxaban—Shock—Prednisone—systemic lupus erythematosus	0.000173	0.000892	CcSEcCtD
Rivaroxaban—Pain—Betamethasone—systemic lupus erythematosus	0.000172	0.00089	CcSEcCtD
Rivaroxaban—Pain—Dexamethasone—systemic lupus erythematosus	0.000172	0.00089	CcSEcCtD
Rivaroxaban—Nervous system disorder—Prednisone—systemic lupus erythematosus	0.000172	0.000889	CcSEcCtD
Rivaroxaban—Tachycardia—Prednisone—systemic lupus erythematosus	0.000171	0.000885	CcSEcCtD
Rivaroxaban—Dizziness—Mycophenolate mofetil—systemic lupus erythematosus	0.000171	0.000884	CcSEcCtD
Rivaroxaban—Skin disorder—Prednisone—systemic lupus erythematosus	0.00017	0.000881	CcSEcCtD
Rivaroxaban—Asthenia—Hydrocortisone—systemic lupus erythematosus	0.000169	0.000874	CcSEcCtD
Rivaroxaban—ABCB1—Allograft Rejection—HLA-DQA1—systemic lupus erythematosus	0.000169	0.00178	CbGpPWpGaD
Rivaroxaban—Vomiting—Cyclosporine—systemic lupus erythematosus	0.000169	0.000872	CcSEcCtD
Rivaroxaban—Rash—Cyclosporine—systemic lupus erythematosus	0.000167	0.000865	CcSEcCtD
Rivaroxaban—Dermatitis—Cyclosporine—systemic lupus erythematosus	0.000167	0.000864	CcSEcCtD
Rivaroxaban—Pruritus—Hydrocortisone—systemic lupus erythematosus	0.000167	0.000862	CcSEcCtD
Rivaroxaban—Ill-defined disorder—Methotrexate—systemic lupus erythematosus	0.000167	0.000861	CcSEcCtD
Rivaroxaban—Headache—Cyclosporine—systemic lupus erythematosus	0.000166	0.000859	CcSEcCtD
Rivaroxaban—Anaemia—Methotrexate—systemic lupus erythematosus	0.000166	0.000858	CcSEcCtD
Rivaroxaban—Feeling abnormal—Betamethasone—systemic lupus erythematosus	0.000166	0.000858	CcSEcCtD
Rivaroxaban—Feeling abnormal—Dexamethasone—systemic lupus erythematosus	0.000166	0.000858	CcSEcCtD
Rivaroxaban—Gastrointestinal pain—Dexamethasone—systemic lupus erythematosus	0.000165	0.000851	CcSEcCtD
Rivaroxaban—Gastrointestinal pain—Betamethasone—systemic lupus erythematosus	0.000165	0.000851	CcSEcCtD
Rivaroxaban—Vomiting—Mycophenolate mofetil—systemic lupus erythematosus	0.000165	0.00085	CcSEcCtD
Rivaroxaban—F10—Metabolism of proteins—ACE—systemic lupus erythematosus	0.000164	0.00173	CbGpPWpGaD
Rivaroxaban—Hypersensitivity—Triamcinolone—systemic lupus erythematosus	0.000164	0.000845	CcSEcCtD
Rivaroxaban—Hypersensitivity—Methylprednisolone—systemic lupus erythematosus	0.000163	0.000843	CcSEcCtD
Rivaroxaban—Rash—Mycophenolate mofetil—systemic lupus erythematosus	0.000163	0.000843	CcSEcCtD
Rivaroxaban—Dermatitis—Mycophenolate mofetil—systemic lupus erythematosus	0.000163	0.000843	CcSEcCtD
Rivaroxaban—Headache—Mycophenolate mofetil—systemic lupus erythematosus	0.000162	0.000838	CcSEcCtD
Rivaroxaban—Malaise—Methotrexate—systemic lupus erythematosus	0.000162	0.000837	CcSEcCtD
Rivaroxaban—Diarrhoea—Hydrocortisone—systemic lupus erythematosus	0.000161	0.000834	CcSEcCtD
Rivaroxaban—CYP2J2—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	0.00016	0.00169	CbGpPWpGaD
Rivaroxaban—Urticaria—Dexamethasone—systemic lupus erythematosus	0.00016	0.000827	CcSEcCtD
Rivaroxaban—Urticaria—Betamethasone—systemic lupus erythematosus	0.00016	0.000827	CcSEcCtD
Rivaroxaban—Dizziness—Prednisolone—systemic lupus erythematosus	0.00016	0.000825	CcSEcCtD
Rivaroxaban—Asthenia—Triamcinolone—systemic lupus erythematosus	0.000159	0.000823	CcSEcCtD
Rivaroxaban—Abdominal pain—Dexamethasone—systemic lupus erythematosus	0.000159	0.000823	CcSEcCtD
Rivaroxaban—Abdominal pain—Betamethasone—systemic lupus erythematosus	0.000159	0.000823	CcSEcCtD
Rivaroxaban—Asthenia—Methylprednisolone—systemic lupus erythematosus	0.000159	0.000821	CcSEcCtD
Rivaroxaban—ABCB1—Allograft Rejection—HLA-DQB1—systemic lupus erythematosus	0.000158	0.00167	CbGpPWpGaD
Rivaroxaban—Nausea—Cyclosporine—systemic lupus erythematosus	0.000158	0.000814	CcSEcCtD
Rivaroxaban—Pruritus—Triamcinolone—systemic lupus erythematosus	0.000157	0.000812	CcSEcCtD
Rivaroxaban—Pruritus—Methylprednisolone—systemic lupus erythematosus	0.000157	0.00081	CcSEcCtD
Rivaroxaban—Dizziness—Hydrocortisone—systemic lupus erythematosus	0.000156	0.000806	CcSEcCtD
Rivaroxaban—Dyspepsia—Prednisone—systemic lupus erythematosus	0.000154	0.000798	CcSEcCtD
Rivaroxaban—Nausea—Mycophenolate mofetil—systemic lupus erythematosus	0.000154	0.000794	CcSEcCtD
Rivaroxaban—Chest pain—Methotrexate—systemic lupus erythematosus	0.000153	0.00079	CcSEcCtD
Rivaroxaban—Rash—Prednisolone—systemic lupus erythematosus	0.000152	0.000787	CcSEcCtD
Rivaroxaban—Dermatitis—Prednisolone—systemic lupus erythematosus	0.000152	0.000786	CcSEcCtD
Rivaroxaban—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic lupus erythematosus	0.000152	0.000785	CcSEcCtD
Rivaroxaban—Diarrhoea—Methylprednisolone—systemic lupus erythematosus	0.000152	0.000783	CcSEcCtD
Rivaroxaban—Fatigue—Prednisone—systemic lupus erythematosus	0.000151	0.000782	CcSEcCtD
Rivaroxaban—Headache—Prednisolone—systemic lupus erythematosus	0.000151	0.000782	CcSEcCtD
Rivaroxaban—Discomfort—Methotrexate—systemic lupus erythematosus	0.000151	0.000781	CcSEcCtD
Rivaroxaban—F10—Hemostasis—JAK1—systemic lupus erythematosus	0.00015	0.00159	CbGpPWpGaD
Rivaroxaban—Constipation—Prednisone—systemic lupus erythematosus	0.00015	0.000775	CcSEcCtD
Rivaroxaban—Vomiting—Hydrocortisone—systemic lupus erythematosus	0.00015	0.000775	CcSEcCtD
Rivaroxaban—ABCB1—Allograft Rejection—IL10—systemic lupus erythematosus	0.000149	0.00157	CbGpPWpGaD
Rivaroxaban—ABCB1—Allograft Rejection—CD40LG—systemic lupus erythematosus	0.000149	0.00157	CbGpPWpGaD
Rivaroxaban—Rash—Hydrocortisone—systemic lupus erythematosus	0.000149	0.000768	CcSEcCtD
Rivaroxaban—Dermatitis—Hydrocortisone—systemic lupus erythematosus	0.000149	0.000768	CcSEcCtD
Rivaroxaban—Headache—Hydrocortisone—systemic lupus erythematosus	0.000148	0.000763	CcSEcCtD
Rivaroxaban—Dizziness—Triamcinolone—systemic lupus erythematosus	0.000147	0.000759	CcSEcCtD
Rivaroxaban—Anaphylactic shock—Methotrexate—systemic lupus erythematosus	0.000147	0.000758	CcSEcCtD
Rivaroxaban—Dizziness—Methylprednisolone—systemic lupus erythematosus	0.000146	0.000757	CcSEcCtD
Rivaroxaban—Infection—Methotrexate—systemic lupus erythematosus	0.000146	0.000753	CcSEcCtD
Rivaroxaban—ABCB1—Allograft Rejection—IL4—systemic lupus erythematosus	0.000145	0.00153	CbGpPWpGaD
Rivaroxaban—Feeling abnormal—Prednisone—systemic lupus erythematosus	0.000145	0.000747	CcSEcCtD
Rivaroxaban—Asthenia—Betamethasone—systemic lupus erythematosus	0.000145	0.000747	CcSEcCtD
Rivaroxaban—Asthenia—Dexamethasone—systemic lupus erythematosus	0.000145	0.000747	CcSEcCtD
Rivaroxaban—Nervous system disorder—Methotrexate—systemic lupus erythematosus	0.000144	0.000743	CcSEcCtD
Rivaroxaban—Gastrointestinal pain—Prednisone—systemic lupus erythematosus	0.000143	0.000741	CcSEcCtD
Rivaroxaban—Nausea—Prednisolone—systemic lupus erythematosus	0.000143	0.000741	CcSEcCtD
Rivaroxaban—Pruritus—Betamethasone—systemic lupus erythematosus	0.000143	0.000737	CcSEcCtD
Rivaroxaban—Pruritus—Dexamethasone—systemic lupus erythematosus	0.000143	0.000737	CcSEcCtD
Rivaroxaban—Skin disorder—Methotrexate—systemic lupus erythematosus	0.000142	0.000736	CcSEcCtD
Rivaroxaban—Vomiting—Triamcinolone—systemic lupus erythematosus	0.000141	0.00073	CcSEcCtD
Rivaroxaban—Vomiting—Methylprednisolone—systemic lupus erythematosus	0.000141	0.000728	CcSEcCtD
Rivaroxaban—F10—Hemostasis—IL2RA—systemic lupus erythematosus	0.00014	0.00148	CbGpPWpGaD
Rivaroxaban—Nausea—Hydrocortisone—systemic lupus erythematosus	0.00014	0.000724	CcSEcCtD
Rivaroxaban—Rash—Triamcinolone—systemic lupus erythematosus	0.00014	0.000723	CcSEcCtD
Rivaroxaban—Dermatitis—Triamcinolone—systemic lupus erythematosus	0.00014	0.000723	CcSEcCtD
Rivaroxaban—Rash—Methylprednisolone—systemic lupus erythematosus	0.00014	0.000722	CcSEcCtD
Rivaroxaban—Dermatitis—Methylprednisolone—systemic lupus erythematosus	0.00014	0.000721	CcSEcCtD
Rivaroxaban—Urticaria—Prednisone—systemic lupus erythematosus	0.000139	0.00072	CcSEcCtD
Rivaroxaban—Headache—Triamcinolone—systemic lupus erythematosus	0.000139	0.000719	CcSEcCtD
Rivaroxaban—Headache—Methylprednisolone—systemic lupus erythematosus	0.000139	0.000717	CcSEcCtD
Rivaroxaban—Abdominal pain—Prednisone—systemic lupus erythematosus	0.000139	0.000717	CcSEcCtD
Rivaroxaban—ABCB1—Allograft Rejection—FASLG—systemic lupus erythematosus	0.000139	0.00146	CbGpPWpGaD
Rivaroxaban—Diarrhoea—Betamethasone—systemic lupus erythematosus	0.000138	0.000712	CcSEcCtD
Rivaroxaban—Diarrhoea—Dexamethasone—systemic lupus erythematosus	0.000138	0.000712	CcSEcCtD
Rivaroxaban—Hypotension—Methotrexate—systemic lupus erythematosus	0.000137	0.000708	CcSEcCtD
Rivaroxaban—ABCB1—Allograft Rejection—FAS—systemic lupus erythematosus	0.000134	0.00141	CbGpPWpGaD
Rivaroxaban—Dizziness—Betamethasone—systemic lupus erythematosus	0.000133	0.000688	CcSEcCtD
Rivaroxaban—Dizziness—Dexamethasone—systemic lupus erythematosus	0.000133	0.000688	CcSEcCtD
Rivaroxaban—ABCB1—Allograft Rejection—IL2RA—systemic lupus erythematosus	0.000133	0.0014	CbGpPWpGaD
Rivaroxaban—Nausea—Triamcinolone—systemic lupus erythematosus	0.000132	0.000682	CcSEcCtD
Rivaroxaban—ABCB1—Allograft Rejection—C3—systemic lupus erythematosus	0.000132	0.00139	CbGpPWpGaD
Rivaroxaban—Nausea—Methylprednisolone—systemic lupus erythematosus	0.000132	0.00068	CcSEcCtD
Rivaroxaban—Dyspnoea—Methotrexate—systemic lupus erythematosus	0.000131	0.000676	CcSEcCtD
Rivaroxaban—ABCB1—Transmembrane transport of small molecules—SLC15A4—systemic lupus erythematosus	0.00013	0.00137	CbGpPWpGaD
Rivaroxaban—CYP3A4—Cytochrome P450 - arranged by substrate type—RXRA—systemic lupus erythematosus	0.00013	0.00137	CbGpPWpGaD
Rivaroxaban—Hypersensitivity—Prednisone—systemic lupus erythematosus	0.000129	0.000668	CcSEcCtD
Rivaroxaban—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—systemic lupus erythematosus	0.000129	0.00136	CbGpPWpGaD
Rivaroxaban—Dyspepsia—Methotrexate—systemic lupus erythematosus	0.000129	0.000667	CcSEcCtD
Rivaroxaban—Vomiting—Betamethasone—systemic lupus erythematosus	0.000128	0.000662	CcSEcCtD
Rivaroxaban—Vomiting—Dexamethasone—systemic lupus erythematosus	0.000128	0.000662	CcSEcCtD
Rivaroxaban—CYP2J2—Metabolism—NAT2—systemic lupus erythematosus	0.000127	0.00134	CbGpPWpGaD
Rivaroxaban—Rash—Betamethasone—systemic lupus erythematosus	0.000127	0.000656	CcSEcCtD
Rivaroxaban—Rash—Dexamethasone—systemic lupus erythematosus	0.000127	0.000656	CcSEcCtD
Rivaroxaban—Dermatitis—Betamethasone—systemic lupus erythematosus	0.000127	0.000656	CcSEcCtD
Rivaroxaban—Dermatitis—Dexamethasone—systemic lupus erythematosus	0.000127	0.000656	CcSEcCtD
Rivaroxaban—Gastrointestinal disorder—Methotrexate—systemic lupus erythematosus	0.000127	0.000654	CcSEcCtD
Rivaroxaban—Fatigue—Methotrexate—systemic lupus erythematosus	0.000126	0.000653	CcSEcCtD
Rivaroxaban—Headache—Dexamethasone—systemic lupus erythematosus	0.000126	0.000652	CcSEcCtD
Rivaroxaban—Headache—Betamethasone—systemic lupus erythematosus	0.000126	0.000652	CcSEcCtD
Rivaroxaban—Asthenia—Prednisone—systemic lupus erythematosus	0.000126	0.00065	CcSEcCtD
Rivaroxaban—Pain—Methotrexate—systemic lupus erythematosus	0.000125	0.000648	CcSEcCtD
Rivaroxaban—Pruritus—Prednisone—systemic lupus erythematosus	0.000124	0.000641	CcSEcCtD
Rivaroxaban—F10—Hemostasis—F2—systemic lupus erythematosus	0.000122	0.00129	CbGpPWpGaD
Rivaroxaban—Feeling abnormal—Methotrexate—systemic lupus erythematosus	0.000121	0.000624	CcSEcCtD
Rivaroxaban—CYP3A5—Biological oxidations—RXRA—systemic lupus erythematosus	0.00012	0.00127	CbGpPWpGaD
Rivaroxaban—Diarrhoea—Prednisone—systemic lupus erythematosus	0.00012	0.00062	CcSEcCtD
Rivaroxaban—ABCB1—Allograft Rejection—HLA-DRB1—systemic lupus erythematosus	0.00012	0.00127	CbGpPWpGaD
Rivaroxaban—Gastrointestinal pain—Methotrexate—systemic lupus erythematosus	0.00012	0.00062	CcSEcCtD
Rivaroxaban—Nausea—Betamethasone—systemic lupus erythematosus	0.00012	0.000618	CcSEcCtD
Rivaroxaban—Nausea—Dexamethasone—systemic lupus erythematosus	0.00012	0.000618	CcSEcCtD
Rivaroxaban—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—systemic lupus erythematosus	0.000117	0.00123	CbGpPWpGaD
Rivaroxaban—Urticaria—Methotrexate—systemic lupus erythematosus	0.000116	0.000602	CcSEcCtD
Rivaroxaban—Dizziness—Prednisone—systemic lupus erythematosus	0.000116	0.0006	CcSEcCtD
Rivaroxaban—Abdominal pain—Methotrexate—systemic lupus erythematosus	0.000116	0.000599	CcSEcCtD
Rivaroxaban—Vomiting—Prednisone—systemic lupus erythematosus	0.000112	0.000576	CcSEcCtD
Rivaroxaban—ABCB1—Allograft Rejection—CD80—systemic lupus erythematosus	0.000111	0.00117	CbGpPWpGaD
Rivaroxaban—Rash—Prednisone—systemic lupus erythematosus	0.000111	0.000572	CcSEcCtD
Rivaroxaban—Dermatitis—Prednisone—systemic lupus erythematosus	0.000111	0.000571	CcSEcCtD
Rivaroxaban—Headache—Prednisone—systemic lupus erythematosus	0.00011	0.000568	CcSEcCtD
Rivaroxaban—Hypersensitivity—Methotrexate—systemic lupus erythematosus	0.000108	0.000558	CcSEcCtD
Rivaroxaban—CYP3A4—Phase 1 - Functionalization of compounds—RXRA—systemic lupus erythematosus	0.000105	0.00111	CbGpPWpGaD
Rivaroxaban—Asthenia—Methotrexate—systemic lupus erythematosus	0.000105	0.000544	CcSEcCtD
Rivaroxaban—Nausea—Prednisone—systemic lupus erythematosus	0.000104	0.000539	CcSEcCtD
Rivaroxaban—Pruritus—Methotrexate—systemic lupus erythematosus	0.000104	0.000536	CcSEcCtD
Rivaroxaban—F10—Hemostasis—ALB—systemic lupus erythematosus	0.000102	0.00107	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	0.000101	0.00107	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—GADD45A—systemic lupus erythematosus	0.000101	0.00107	CbGpPWpGaD
Rivaroxaban—Diarrhoea—Methotrexate—systemic lupus erythematosus	0.0001	0.000518	CcSEcCtD
Rivaroxaban—CYP3A4—Biological oxidations—NAT2—systemic lupus erythematosus	9.98e-05	0.00105	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metapathway biotransformation—NAT2—systemic lupus erythematosus	9.84e-05	0.00104	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—NOS3—systemic lupus erythematosus	9.71e-05	0.00102	CbGpPWpGaD
Rivaroxaban—Dizziness—Methotrexate—systemic lupus erythematosus	9.69e-05	0.000501	CcSEcCtD
Rivaroxaban—F10—Metabolism of proteins—F2—systemic lupus erythematosus	9.62e-05	0.00101	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—JUNB—systemic lupus erythematosus	9.52e-05	0.00101	CbGpPWpGaD
Rivaroxaban—Vomiting—Methotrexate—systemic lupus erythematosus	9.32e-05	0.000482	CcSEcCtD
Rivaroxaban—Rash—Methotrexate—systemic lupus erythematosus	9.24e-05	0.000478	CcSEcCtD
Rivaroxaban—Dermatitis—Methotrexate—systemic lupus erythematosus	9.23e-05	0.000477	CcSEcCtD
Rivaroxaban—Headache—Methotrexate—systemic lupus erythematosus	9.18e-05	0.000475	CcSEcCtD
Rivaroxaban—CYP2J2—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	9.1e-05	0.00096	CbGpPWpGaD
Rivaroxaban—ABCB1—Allograft Rejection—IFNG—systemic lupus erythematosus	8.76e-05	0.000925	CbGpPWpGaD
Rivaroxaban—Nausea—Methotrexate—systemic lupus erythematosus	8.71e-05	0.00045	CcSEcCtD
Rivaroxaban—F10—Metabolism of proteins—CCL2—systemic lupus erythematosus	8.57e-05	0.000905	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—RXRA—systemic lupus erythematosus	8.35e-05	0.000881	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—IL2—systemic lupus erythematosus	8.23e-05	0.000869	CbGpPWpGaD
Rivaroxaban—ABCB1—HIF-1-alpha transcription factor network—EP300—systemic lupus erythematosus	8.07e-05	0.000851	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	7.96e-05	0.00084	CbGpPWpGaD
Rivaroxaban—ABCB1—Allograft Rejection—IL2—systemic lupus erythematosus	7.79e-05	0.000822	CbGpPWpGaD
Rivaroxaban—ABCB1—HIF-1-alpha transcription factor network—VEGFA—systemic lupus erythematosus	7.64e-05	0.000806	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—EP300—systemic lupus erythematosus	7.39e-05	0.00078	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—RXRA—systemic lupus erythematosus	7.14e-05	0.000753	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—VEGFA—systemic lupus erythematosus	7e-05	0.000738	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—systemic lupus erythematosus	6.84e-05	0.000721	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	6.62e-05	0.000699	CbGpPWpGaD
Rivaroxaban—ABCB1—Allograft Rejection—VEGFA—systemic lupus erythematosus	6.62e-05	0.000698	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—systemic lupus erythematosus	6.59e-05	0.000696	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—TGFB1—systemic lupus erythematosus	6.42e-05	0.000678	CbGpPWpGaD
Rivaroxaban—ABCB1—Allograft Rejection—TGFB1—systemic lupus erythematosus	6.07e-05	0.000641	CbGpPWpGaD
Rivaroxaban—ABCB1—Allograft Rejection—TNF—systemic lupus erythematosus	5.67e-05	0.000599	CbGpPWpGaD
Rivaroxaban—CYP3A4—Biological oxidations—RXRA—systemic lupus erythematosus	5.59e-05	0.00059	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—PPARG—systemic lupus erythematosus	4.51e-05	0.000476	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—systemic lupus erythematosus	4.15e-05	0.000438	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—ALB—systemic lupus erythematosus	4.05e-05	0.000428	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—systemic lupus erythematosus	3.93e-05	0.000414	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—NOS3—systemic lupus erythematosus	3.88e-05	0.000409	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—NAT2—systemic lupus erythematosus	3.67e-05	0.000387	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—systemic lupus erythematosus	3.62e-05	0.000382	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—PTGS2—systemic lupus erythematosus	3.54e-05	0.000374	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—systemic lupus erythematosus	3.45e-05	0.000364	CbGpPWpGaD
Rivaroxaban—ABCB1—Transmembrane transport of small molecules—RXRA—systemic lupus erythematosus	3.31e-05	0.00035	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—systemic lupus erythematosus	3.27e-05	0.000345	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—systemic lupus erythematosus	3e-05	0.000316	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—EP300—systemic lupus erythematosus	2.95e-05	0.000311	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—systemic lupus erythematosus	2.8e-05	0.000295	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—NAT2—systemic lupus erythematosus	2.77e-05	0.000292	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—RXRA—systemic lupus erythematosus	2.06e-05	0.000217	CbGpPWpGaD
Rivaroxaban—ABCB1—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	1.88e-05	0.000199	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—NAT2—systemic lupus erythematosus	1.71e-05	0.00018	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—RXRA—systemic lupus erythematosus	1.55e-05	0.000164	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—PPARG—systemic lupus erythematosus	1.3e-05	0.000137	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—ALB—systemic lupus erythematosus	1.17e-05	0.000123	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—NOS3—systemic lupus erythematosus	1.12e-05	0.000118	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—PTGS2—systemic lupus erythematosus	1.02e-05	0.000108	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—PPARG—systemic lupus erythematosus	9.8e-06	0.000103	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—RXRA—systemic lupus erythematosus	9.56e-06	0.000101	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—ALB—systemic lupus erythematosus	8.81e-06	9.3e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—EP300—systemic lupus erythematosus	8.5e-06	8.97e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—NOS3—systemic lupus erythematosus	8.43e-06	8.9e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—PTGS2—systemic lupus erythematosus	7.71e-06	8.14e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—EP300—systemic lupus erythematosus	6.41e-06	6.77e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—PPARG—systemic lupus erythematosus	6.04e-06	6.37e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—ALB—systemic lupus erythematosus	5.43e-06	5.73e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—NOS3—systemic lupus erythematosus	5.19e-06	5.48e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—PTGS2—systemic lupus erythematosus	4.75e-06	5.01e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—EP300—systemic lupus erythematosus	3.95e-06	4.17e-05	CbGpPWpGaD
